Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 493

1.

Incidence and in-hospital Safety Outcomes of Patients undergoing Percutaneous Mitral Valve Edge-to-Edge Repair Using MitraClip® - 5 year German national patient sample including 13,575 implants.

von Bardeleben RS, Hobohm L, Kreidel F, Ostad MA, Schulz E, Konstantinides S, Lankeit M, Feldman T, Münzel T, Keller K.

EuroIntervention. 2019 Jan 22. pii: EIJ-D-18-00961. doi: 10.4244/EIJ-D-18-00961. [Epub ahead of print]

PMID:
30666965
2.

Brentuximab Vedotin Plus Chemotherapy in North American Patients with Newly Diagnosed Stage III or IV Hodgkin Lymphoma.

Ramchandren R, Advani RH, Ansell SM, Bartlett NL, Chen R, Connors JM, Feldman T, Forero A, Friedberg JW, Gopal AK, Gordon LI, Kuruvilla J, Savage KJ, Younes A, Engley G, Manley TJ, Fenton K, Straus DJ.

Clin Cancer Res. 2019 Jan 7. pii: clincanres.2435.2018. doi: 10.1158/1078-0432.CCR-18-2435. [Epub ahead of print]

PMID:
30617130
3.

Transcatheter mitral valve repair/replacement for primary mitral regurgitation.

Feldman T, Fernandes E, Levisay JP.

Ann Cardiothorac Surg. 2018 Nov;7(6):755-763. doi: 10.21037/acs.2018.07.04.

4.

Continuous Direct Left Atrial Pressure: Intraprocedural Measurement Predicts Clinical Response Following MitraClip Therapy.

Kuwata S, Taramasso M, Czopak A, Luciani M, Pozzoli A, Ho E, Ferrero Guadagnoli A, Saccocci M, Gaemperli O, Nietlispach F, Zuber M, Feldman T, Maisano F.

JACC Cardiovasc Interv. 2018 Dec 21. pii: S1936-8798(18)31666-2. doi: 10.1016/j.jcin.2018.07.051. [Epub ahead of print]

PMID:
30594511
5.

One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.

Ailawadi G, Lim DS, Mack MJ, Trento A, Kar S, Grayburn PA, Glower DD, Wang A, Foster E, Qasim A, Weissman NJ, Ellis J, Crosson L, Fan F, Kron IL, Pearson PJ, Feldman T; EVEREST II Investigators.

Circulation. 2019 Jan 2;139(1):37-47. doi: 10.1161/CIRCULATIONAHA.117.031733.

PMID:
30586701
6.

Mogamulizumab versus investigator choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.

Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A, Humphrey J, Kurman M, Moriya J, Dwyer K, Leoni M, Conlon K, Cook L, Gonsky J, Horwitz SM.

Haematologica. 2018 Dec 20. pii: haematol.2018.205096. doi: 10.3324/haematol.2018.205096. [Epub ahead of print]

7.

Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.

Bair SM, Strelec LE, Feldman TA, Ahmed G, Armand P, Shah NN, Singavi AN, Reddy N, Khan N, Andreadis C, Vu K, Huntington SF, Giri S, Ujjani C, Howlett C, Faheem M, Youngman MR, Nasta SD, Landsburg DJ, Schuster SJ, Svoboda J.

Oncologist. 2018 Dec 19. pii: theoncologist.2018-0538. doi: 10.1634/theoncologist.2018-0538. [Epub ahead of print]

PMID:
30568021
8.

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.

Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group.

Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Erratum in: Lancet. 2019 Jan 19;393(10168):228.

PMID:
30522922
9.

Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.

Wessler J, Kaye D, Gustafsson F, Petrie MC, Hasenfuβ G, Lam CSP, Borlaug BA, Komtebedde J, Feldman T, Shah SJ, Burkhoff D; REDUCE-LAP-HF Trial Investigators and Advisors.

Circ Heart Fail. 2018 Aug;11(8):e004540. doi: 10.1161/CIRCHEARTFAILURE.117.004540.

PMID:
30354556
10.

Primary MR remains undertreated.

Feldman T, Smith R 2nd, Popma JJ.

Cardiovasc Revasc Med. 2018 Dec;19(8):905-906. doi: 10.1016/j.carrev.2018.10.015. Epub 2018 Oct 15. No abstract available.

PMID:
30340954
11.

2018 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institutional recommendations and requirements for transcatheter aortic valve replacement: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Bavaria JE, Tommaso CL, Brindis RG, Carroll JD, Michael Deeb G, Feldman TE, Gleason TG, Horlick EM, Kavinsky CJ, Kumbhani DJ, Craig Miller D, Allen Seals A, Shahian DM, Shemin RJ, Sundt TM 3rd, Thourani VH.

Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27811. [Epub ahead of print] No abstract available.

PMID:
30265423
12.

Open Atrial Transcatheter Mitral Valve Replacement in Patients With Mitral Annular Calcification.

Russell HM, Guerrero ME, Salinger MH, Manzuk MA, Pursnani AK, Wang D, Nemeh H, Sakhuja R, Melnitchouk S, Pershad A, Fang HK, Said SM, Kauten J, Tang GHL, Aldea G, Feldman TE, Bapat VN, George IM.

J Am Coll Cardiol. 2018 Sep 25;72(13):1437-1448. doi: 10.1016/j.jacc.2018.07.033.

PMID:
30236304
13.

Lipoprotein Sub-Fractions by Ion-Mobility Analysis and Its Association with Subclinical Coronary Atherosclerosis in High-Risk Individuals.

Aneni EC, Osondu CU, De La Cruz J, Martin SS, Blaha MJ, Younus A, Feldman T, Agatston AS, Veledar E, Nasir K.

J Atheroscler Thromb. 2019 Jan 1;26(1):50-63. doi: 10.5551/jat.40741. Epub 2018 Sep 14.

14.

Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.

Chihara D, Wong S, Feldman T, Fanale MA, Sanchez L, Connors JM, Savage KJ, Oki Y.

Hematol Oncol. 2018 Sep 12. doi: 10.1002/hon.2560. [Epub ahead of print]

PMID:
30209819
15.

Survival Advantage of MitraClip® Over Medical Treatment in Patients with Mitral Regurgitation: A Meta-Analysis.

Benito-González T, Estévez-Loureiro R, Iglesias-Gárriz I, Gualis J, Pérez de Prado A, Garrote C, Swaans MJ, S Van der Heyden JA, Feldman T, Giannini C, Alonso D, Rodriguez-Santamarta M, Castaño M, Fernández-Vázquez F.

J Heart Valve Dis. 2017 Nov;26(6):651-658.

PMID:
30207115
16.

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.

Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, Nielsen CD, van der Harst P, Hoendermis E, Penicka M, Bartunek J, Fail PS, Kaye DM, Walton A, Petrie MC, Walker N, Basuray A, Yakubov S, Hummel SL, Chetcuti S, Forde-McLean R, Herrmann HC, Burkhoff D, Massaro JM, Cleland JGF, Mauri L.

JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.

PMID:
30167646
17.

Transcatheter mitral valve repair: review of the clinical evidence.

Taramasso M, Feldman T, Maisano F.

EuroIntervention. 2018 Aug 31;14(AB):AB91-AB100. doi: 10.4244/EIJ-D-18-00511.

18.

Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.

Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, Kapadia SR, McCarthy PM, Lim DS, Udelson JE, Zile MR, Gammie JS, Gillinov AM, Glower DD, Heimansohn DA, Suri RM, Ellis JT, Shu Y, Kar S, Weissman NJ, Stone GW.

Am Heart J. 2018 Nov;205:1-11. doi: 10.1016/j.ahj.2018.07.021. Epub 2018 Aug 1.

PMID:
30134187
19.

Reply: Patient-Specific Computer Modeling for the Planning of Transcatheter Mitral Valve Replacement.

Guerrero M, Urena M, Wang DD, O'Neill W, Feldman T.

J Am Coll Cardiol. 2018 Aug 21;72(8):958. doi: 10.1016/j.jacc.2018.06.020. No abstract available.

PMID:
30115239
20.

Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients.

Kar S, Feldman T, Qasim A, Trento A, Kapadia S, Pedersen W, Lim DS, Kipperman R, Smalling RW, Bajwa T, Hermann HC, Hermiller JB, Lasala JM, Reisman M, Glower D, Mauri L, Whitlow P; EVEREST II Investigators.

Heart. 2018 Aug 4. pii: heartjnl-2017-312605. doi: 10.1136/heartjnl-2017-312605. [Epub ahead of print]

PMID:
30077993
21.

2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.

Bavaria JE, Tommaso CL, Brindis RG, Carroll JD, Deeb GM, Feldman TE, Gleason TG, Horlick EM, Kavinsky CJ, Kumbhani DJ, Miller DC, Seals AA, Shahian DM, Shemin RJ, Sundt TM 3rd, Thourani VH.

J Am Coll Cardiol. 2018 Jul 18. pii: S0735-1097(18)35377-4. doi: 10.1016/j.jacc.2018.07.002. [Epub ahead of print] No abstract available. Erratum in: J Am Coll Cardiol. 2018 Aug 3;:.

PMID:
30031107
22.

2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.

Bavaria JE, Tommaso CL, Brindis RG, Carroll JD, Deeb GM, Feldman TE, Gleason TG, Horlick EM, Kavinsky CJ, Kumbhani DJ, Miller DC, Seals AA, Shahian DM, Shemin RJ, Sundt TM 3rd, Thourani VH.

Ann Thorac Surg. 2018 Jul 31. pii: S0003-4975(18)30979-2. doi: 10.1016/j.athoracsur.2018.07.001. [Epub ahead of print] No abstract available. Erratum in: Ann Thorac Surg. 2018 Aug 9;:.

PMID:
30030976
23.

Valve-in-valve TAVR using the SAPIEN 3 transcatheter heart valve: still plagued by patient-prosthesis mismatch.

Saxon JT, Cohen DJ, Feldman T.

EuroIntervention. 2018 Jul 20;14(4):e377-e379. doi: 10.4244/EIJV14I4A66. No abstract available.

24.

Engineering glycoside hydrolase stability by the introduction of zinc binding.

Ellinghaus TL, Pereira JH, McAndrew RP, Welner DH, DeGiovanni AM, Guenther JM, Tran HM, Feldman T, Simmons BA, Sale KL, Adams PD.

Acta Crystallogr D Struct Biol. 2018 Jul 1;74(Pt 7):702-710. doi: 10.1107/S2059798318006678. Epub 2018 Jun 27.

25.

Survival After MitraClip Treatment Compared to Surgical and Conservative Treatment for High-Surgical-Risk Patients With Mitral Regurgitation.

Kortlandt F, Velu J, Schurer R, Hendriks T, Van den Branden B, Bouma B, Feldman T, Kelder J, Bakker A, Post M, Van der Harst P, Eefting F, Swaans M, Rensing B, Baan J Jr, Van der Heyden J.

Circ Cardiovasc Interv. 2018 Jun;11(6):e005985. doi: 10.1161/CIRCINTERVENTIONS.117.005985.

PMID:
29895598
26.

Spectral analysis of fundus autofluorescence pattern as a tool to detect early stages of degeneration in the retina and retinal pigment epithelium.

Feldman TB, Yakovleva MA, Larichev AV, Arbukhanova PM, Radchenko AS, Borzenok SA, Kuzmin VA, Ostrovsky MA.

Eye (Lond). 2018 Sep;32(9):1440-1448. doi: 10.1038/s41433-018-0109-0. Epub 2018 May 22.

PMID:
29786089
27.

1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification.

Guerrero M, Urena M, Himbert D, Wang DD, Eleid M, Kodali S, George I, Chakravarty T, Mathur M, Holzhey D, Pershad A, Fang HK, O'Hair D, Jones N, Mahadevan VS, Dumonteil N, Rodés-Cabau J, Piazza N, Ferrari E, Ciaburri D, Nejjari M, DeLago A, Sorajja P, Zahr F, Rajagopal V, Whisenant B, Shah PB, Sinning JM, Witkowski A, Eltchaninoff H, Dvir D, Martin B, Attizzani GF, Gaia D, Nunes NSV, Fassa AA, Kerendi F, Pavlides G, Iyer V, Kaddissi G, Witzke C, Wudel J, Mishkel G, Raybuck B, Wang C, Waksman R, Palacios I, Cribier A, Webb J, Bapat V, Reisman M, Makkar R, Leon M, Rihal C, Vahanian A, O'Neill W, Feldman T.

J Am Coll Cardiol. 2018 May 1;71(17):1841-1853. doi: 10.1016/j.jacc.2018.02.054.

PMID:
29699609
28.

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.

Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko YH, Cabrera ME, Horwitz S, Kim WS, Shustov A, Foss FM, Nagler A, Carson K, Pinter-Brown LC, Montoto S, Spina M, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Gabus R, Vose JM, Advani RH; T cell Project Network.

Br J Haematol. 2018 Jun;181(6):760-769. doi: 10.1111/bjh.15258. Epub 2018 Apr 19.

29.

Harnessing mHealth technologies to increase physical activity and prevent cardiovascular disease.

Feldman DI, Theodore Robison W, Pacor JM, Caddell LC, Feldman EB, Deitz RL, Feldman T, Martin SS, Nasir K, Blaha MJ.

Clin Cardiol. 2018 Jul;41(7):985-991. doi: 10.1002/clc.22968. Epub 2018 Jul 20. Review.

30.

Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature.

Rufian-Andujar S, Iftikhar O, Salinger M, Saucedo J, Feldman T, Guerrero M.

Cardiovasc Revasc Med. 2018 Oct - Nov;19(7 Pt B):874-878. doi: 10.1016/j.carrev.2018.02.011. Epub 2018 Feb 23. Review.

PMID:
29636301
31.

Impact of the MitraClip Procedure on Left Atrial Strain and Strain Rate.

Gucuk Ipek E, Singh S, Viloria E, Feldman T, Grayburn P, Foster E, Qasim A.

Circ Cardiovasc Imaging. 2018 Mar;11(3):e006553. doi: 10.1161/CIRCIMAGING.117.006553.

PMID:
29535132
32.

Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial.

Asch FM, Vannan MA, Singh S, Khandheria B, Little SH, Allocco DJ, Meredith IT, Feldman TE, Reardon MJ, Weissman NJ.

Circulation. 2018 Jun 12;137(24):2557-2567. doi: 10.1161/CIRCULATIONAHA.118.034129. Epub 2018 Mar 12.

PMID:
29530883
33.

Intra-cardiac echo for left atrial appendage occlusion.

Feldman T, Nazari J.

Catheter Cardiovasc Interv. 2018 Feb 1;91(2):362-363. doi: 10.1002/ccd.27504.

PMID:
29405595
34.

Psychological Factors and Their Association with Ideal Cardiovascular Health Among Women and Men.

Mathews L, Ogunmoroti O, Nasir K, Blumenthal RS, Utuama OA, Rouseff M, Das S, Veledar E, Feldman T, Agatston A, Zhao D, Michos ED.

J Womens Health (Larchmt). 2018 May;27(5):709-715. doi: 10.1089/jwh.2017.6563. Epub 2018 Jan 29.

PMID:
29377738
35.

Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.

Dvir D, Bourguignon T, Otto CM, Hahn RT, Rosenhek R, Webb JG, Treede H, Sarano ME, Feldman T, Wijeysundera HC, Topilsky Y, Aupart M, Reardon MJ, Mackensen GB, Szeto WY, Kornowski R, Gammie JS, Yoganathan AP, Arbel Y, Borger MA, Simonato M, Reisman M, Makkar RR, Abizaid A, McCabe JM, Dahle G, Aldea GS, Leipsic J, Pibarot P, Moat NE, Mack MJ, Kappetein AP, Leon MB; VIVID (Valve in Valve International Data) Investigators.

Circulation. 2018 Jan 23;137(4):388-399. doi: 10.1161/CIRCULATIONAHA.117.030729. Review.

PMID:
29358344
36.

Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.

Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Gleason TG, Tchétché D, Rovin JD, Buchbinder M, Meredith IT, Götberg M, Bjursten H, Meduri C, Salinger MH, Allocco DJ, Dawkins KD.

JAMA. 2018 Jan 2;319(1):27-37. doi: 10.1001/jama.2017.19132.

37.

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.

Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, Sehn LH, Feldman T, Abramson JS, Kritharis A, Hernandez-Ilizaliturri FJ, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA, Jagadeesh D, Woda B, Gupta GK, Gascoyne RD, Jaffe ES, Evens AM.

Blood Adv. 2017 Dec 11;1(26):2600-2609. doi: 10.1182/bloodadvances.2017009472. eCollection 2017 Dec 12.

38.

Expression of naturally ionic liquid-tolerant thermophilic cellulases in Aspergillus niger.

Amaike Campen S, Lynn J, Sibert SJ, Srikrishnan S, Phatale P, Feldman T, Guenther JM, Hiras J, Tran YTA, Singer SW, Adams PD, Sale KL, Simmons BA, Baker SE, Magnuson JK, Gladden JM.

PLoS One. 2017 Dec 27;12(12):e0189604. doi: 10.1371/journal.pone.0189604. eCollection 2017.

39.

The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis.

Osondu CU, Vo B, Oni ET, Blaha MJ, Veledar E, Feldman T, Agatston AS, Nasir K, Aneni EC.

Vasc Med. 2018 Feb;23(1):9-20. doi: 10.1177/1358863X17725809. Epub 2017 Dec 15. Review.

PMID:
29243995
40.

A new species of <i>Marmara</i> (Lepidoptera: Gracillariidae: Marmarinae), with an Annotated List of Known Hostplants for the Genus.

Eiseman CS, Davis DR, Blyth JA, Wagner DL, Palmer MW, Feldman TS.

Zootaxa. 2017 Oct 17;4337(2):198-222. doi: 10.11646/zootaxa.4337.2.2.

PMID:
29242439
41.

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.

Herrera AF, Moskowitz AJ, Bartlett NL, Vose JM, Ramchandren R, Feldman TA, LaCasce AS, Ansell SM, Moskowitz CH, Fenton K, Ogden CA, Taft D, Zhang Q, Kato K, Campbell M, Advani RH.

Blood. 2018 Mar 15;131(11):1183-1194. doi: 10.1182/blood-2017-10-811224. Epub 2017 Dec 11.

42.

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group.

N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. Erratum in: N Engl J Med. 2018 Mar 1;378(9):878.

43.

Improvements in Outcomes and Disparities of ST-Segment-Elevation Myocardial Infarction Care: The Miami-Dade County ST-Segment-Elevation Myocardial Infarction Network Project.

Damluji AA, Myerburg RJ, Chongthammakun V, Feldman T, Rosenberg DG, Schrank KS, Keroff FM, Grossman M, Cohen MG, Moscucci M.

Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12). pii: e004038. doi: 10.1161/CIRCOUTCOMES.117.004038. No abstract available.

PMID:
29217676
44.

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.

Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ; REDUCE LAP-HF I Investigators and Study Coordinators.

Circulation. 2018 Jan 23;137(4):364-375. doi: 10.1161/CIRCULATIONAHA.117.032094. Epub 2017 Nov 15.

PMID:
29142012
45.

Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report.

Sorajja P, Vemulapalli S, Feldman T, Mack M, Holmes DR Jr, Stebbins A, Kar S, Thourani V, Ailawadi G.

J Am Coll Cardiol. 2017 Nov 7;70(19):2315-2327. doi: 10.1016/j.jacc.2017.09.015.

46.

Association between self-rated health and ideal cardiovascular health: The Baptist Health South Florida Employee Study.

Ogunmoroti O, Utuama OA, Salami JA, Valero-Elizondo J, Spatz ES, Rouseff M, Parris D, Das S, Guzman H, Agatston A, Feldman T, Veledar E, Maziak W, Nasir K.

J Public Health (Oxf). 2018 Dec 1;40(4):e456-e463. doi: 10.1093/pubmed/fdx140.

PMID:
29045671
47.

A novel Fer/FerT targeting compound selectively evokes metabolic stress and necrotic death in malignant cells.

Elkis Y, Cohen M, Yaffe E, Satmary-Tusk S, Feldman T, Hikri E, Nyska A, Feiglin A, Ofran Y, Shpungin S, Nir U.

Nat Commun. 2017 Oct 16;8(1):940. doi: 10.1038/s41467-017-00832-w.

48.

Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study.

Praz F, Spargias K, Chrissoheris M, Büllesfeld L, Nickenig G, Deuschl F, Schueler R, Fam NP, Moss R, Makar M, Boone R, Edwards J, Moschovitis A, Kar S, Webb J, Schäfer U, Feldman T, Windecker S.

Lancet. 2017 Aug 19;390(10096):773-780. doi: 10.1016/S0140-6736(17)31600-8.

PMID:
28831993
49.

Gene Duplication in Pseudomonas aeruginosa Improves Growth on Adenosine.

Toussaint JP, Farrell-Sherman A, Feldman TP, Smalley NE, Schaefer AL, Greenberg EP, Dandekar AA.

J Bacteriol. 2017 Oct 3;199(21). pii: e00261-17. doi: 10.1128/JB.00261-17. Print 2017 Nov 1.

50.

Balloon aortic valvuloplasty in the TAVR era: Not so new but definitely improved.

Feldman T, Guerrero M.

Catheter Cardiovasc Interv. 2017 Aug 1;90(2):311-312. doi: 10.1002/ccd.27219.

PMID:
28805033

Supplemental Content

Loading ...
Support Center